Hans Lindgren
11 – 20 of 27
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Mortality with paclitaxel-coated devices in peripheral artery disease
(
- Contribution to journal › Article
-
Mark
Eight-year outcome after invasive treatment of infrainguinal intermittent claudication : A population-based analysis from the Swedish vascular register (Swedvasc)
(
- Contribution to journal › Article
- 2019
-
Mark
Onyx Embolization for Occlusion of the Proximal Internal Iliac Artery During EVAR in Patients with Unsuitable Landing Zones in the Common Iliac Artery
(
- Contribution to journal › Article
-
Mark
Introduction of prostate artery embolization (PAE) in Sweden
(
- Contribution to journal › Article
-
Mark
Prostataartärembolisering introducerad i Sverige
(
- Contribution to journal › Article
- 2018
-
Mark
Assessment of EVAR Competence : Validity of a Novel Rating Scale (EVARATE) in a Simulated Setting
(
- Contribution to journal › Article
-
Mark
Primary Stenting of the Superficial Femoral Artery in Patients with Intermittent Claudication Has Durable Effects on Health-Related Quality of Life at 24 Months : Results of a Randomized Controlled Trial
(
- Contribution to journal › Article
-
Mark
Cost-effectiveness of revascularization in patients with intermittent claudication
(
- Contribution to journal › Article
- 2017
-
Mark
Patients With Intermittent Claudication and Chronic Widespread Pain Improves in Health-Related Quality of Life After Invasive but Not After Noninvasive Treatment
(
- Contribution to journal › Article
-
Mark
Primary Stenting of the Superficial Femoral Artery in Intermittent Claudication Improves Health Related Quality of Life, ABI and Walking Distance : 12 Month Results of a Controlled Randomised Multicentre Trial
(
- Contribution to journal › Article